ArticlePlastic and reconstructive surgery. Global open2020
Building a Multidisciplinary Comprehensive Academic Lymphedema Program.
Article in Plastic and reconstructive surgery. Global open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Lymphatic Ultrasound in Longitudinal Decision-making for Lymphedema: A Narrative Review Integrating Conservative and Surgical Management.Plastic and reconstructive surgery. Global open · 2026Article
- "Debulking" the future of lymphedema surgery: A narrative review.JPRAS open · 2026Review
- Gatekeeper or Pathfinder? The Evolving Role of Lymphedema Surgeons in the Assessment of Limb Swelling.Journal of clinical medicine · 2026Article
- Reimagining Recruitment and Retention in Academic Plastic Surgery.Plastic and reconstructive surgery. Global open · 2026Article
- Expert-consensus on lymphedema surgeries: candidacy, prehabilitation, and postoperative care.Medical oncology (Northwood, London, England) · 2024Article
- A Primer for Success as an Early Career Academic Plastic Surgeon.Plastic and reconstructive surgery. Global open · 2022Article
- Healthcare Practitioners' Knowledge of Lymphedema.International journal of vascular medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphedema is a debilitating clinical condition predominantly affecting survivors of cancer. It adversely affects patients' quality of life and results in substantial cost burdens to both patients and the healthcare system. Specialist lymphedema care is optimally provided within integrated clinical programs that align the necessary specialties to provide patient-focused, multidisciplinary, structured, and coordinated care. This article examines our experience building a specialist lymphedema academic program.
methodsWe describe the critical components necessary for constructing a multidisciplinary comprehensive academic lymphedema program. Furthermore, lessons learned from our experience building a successful lymphedema program are discussed.
resultsBuilding a comprehensive academic lymphedema program requires institutional support and engagement of stakeholders to establish the necessary infrastructure for comprehensive patient care. This includes the infrastructure for outpatient clinical assessment, diagnostic investigations, radiological imaging, collection of outcomes metrics, non-surgical treatment delivered by lymphedema-specialist therapists, surgical procedures using specialized equipment, and integration of an outpatient framework for comprehensive patient evaluation during follow-up at standardized time intervals.
conclusionsThis article examines our experience building a multidisciplinary comprehensive academic lymphedema program and provides a structured roadmap to benefit others that are embarking on this mission.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.